FDA Inspection 1079181 — Orlando Clinical Research Center
The FDA completed an inspection of Orlando Clinical Research Center on Jan 23, 2019 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Orlando, FL (United States)
Additional Details
Clinical BA/BE